| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |